Market accessOfficial

SÚKL launches expanded ASTERx system for pricing and reimbursement proceedings, retires Verso

🇨🇿 SÚKL · Fri 20 Nov 2026

The Czech medicines agency has moved case searches, file documents and automated data feeds for pricing and reimbursement onto ASTERx, with Verso to be shut down shortly.

The Czech State Institute for Drug Control (SÚKL) has launched its ASTERx information system in an expanded scope for pricing and reimbursement regulation. The notice, published on 20 November 2026 by the agency's pricing and reimbursement section, follows an earlier announcement and changes how administrative proceedings are searched, how case-file documents are viewed online and how data is retrieved automatically.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: SÚKL ↗

Article written by VigiEye from the official source (SÚKL). AI-assisted; check the source before acting.